Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 2,906Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 8Eli Lilly

02 2Qilu Pharmaceutical

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

LASMIDITAN SUCCINATE

Brand Name : REYVOW

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 50MG BASE

Packaging :

Approval Date : 2020-01-31

Application Number : 211280

Regulatory Info : RX

Registration Country : USA

blank

02

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

LASMIDITAN SUCCINATE

Brand Name : REYVOW

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 100MG BASE

Packaging :

Approval Date : 2020-01-31

Application Number : 211280

Regulatory Info : RX

Registration Country : USA

blank

03

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

LASMIDITAN SUCCINATE

Brand Name : REYVOW

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 200MG BASE

Packaging :

Approval Date : 2020-12-18

Application Number : 211280

Regulatory Info : DISCN

Registration Country : USA

blank

04

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Lasmiditan Succinate

Brand Name : Rayvow

Dosage Form : Film Coated Tablet

Dosage Strength : 100mg

Packaging :

Approval Date : 17/08/2022

Application Number : 20201107000021

Regulatory Info : Approved

Registration Country : Sweden

blank

05

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Lasmiditan Succinate

Brand Name : Rayvow

Dosage Form : Film Coated Tablet

Dosage Strength : 200mg

Packaging :

Approval Date : 17/08/2022

Application Number : 20201107000038

Regulatory Info : Approved

Registration Country : Sweden

blank

06

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Lasmiditan Succinate

Brand Name : Rayvow

Dosage Form : Film Coated Tablet

Dosage Strength : 50mg

Packaging :

Approval Date : 17/08/2022

Application Number : 20201107000014

Regulatory Info : Approved

Registration Country : Sweden

blank

07

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Lasmiditan Succinate

Brand Name : Rayvow

Dosage Form : Film Coated Tablet

Dosage Strength : 100MG

Packaging :

Approval Date : 2022-09-16

Application Number : 1211587016

Regulatory Info : Authorized

Registration Country : Spain

blank

08

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Lasmiditan Succinate

Brand Name : Rayvow

Dosage Form : Film Coated Tablet

Dosage Strength : 50MG

Packaging :

Approval Date : 2022-09-16

Application Number : 1211587006

Regulatory Info : Authorized

Registration Country : Spain

blank

09

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

LASMIDITAN

Brand Name : LASMIDITAN

Dosage Form : TABLET

Dosage Strength : 100MG

Packaging :

Approval Date :

Application Number : 219350

Regulatory Info :

Registration Country : USA

blank

10

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

LASMIDITAN

Brand Name : LASMIDITAN

Dosage Form : TABLET

Dosage Strength : 50MG

Packaging :

Approval Date :

Application Number : 219350

Regulatory Info :

Registration Country : USA

blank